Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
about
Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature reviewEfficacy of adjunctive treatments added to olanzapine or clozapine for weight control in patients with schizophrenia: a systematic review and meta-analysisPolypharmacy for schizophrenia.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Pharmacotherapy for treatment-resistant schizophrenia.Treatment-resistant Schizophrenia: Evidence-based StrategiesEfficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials.Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover studyPharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What's the Evidence?Sertindole in schizophrenia: efficacy and safety issues.Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.Glutamatergic agents for schizophrenia: current evidence and perspectives.Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia.Beyond dopamine: glutamate as a target for future antipsychotics.Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.
P2860
Q24598636-8D4DDF4D-BAF7-44E9-80DD-270BA79D7374Q27691321-9F9F4C26-8798-4E4B-8DD0-8404E42C0B1BQ33634660-FC7E48BF-9055-40C0-A963-5AB08A81A06CQ34315836-5000132A-B70D-4335-8886-F75E872160AEQ34640811-8483CF5B-A771-4529-8C88-9C669327C1D0Q34879109-E8BE7A6F-2FC5-457C-A791-9C74136E2124Q35964353-930FC5EC-B31E-4FD6-B332-EC81590E81AFQ36232038-5A5D8BCB-9DEF-4843-85E2-B0BB40CC03D0Q37111872-BD9C5C44-606F-4D8F-9D02-B0186C3673C7Q38173359-0851CAEB-F684-4478-8C1A-F340E828BBEBQ38236032-71E9F194-C306-4D24-A4B5-686101E54BC9Q38256894-5E9493B0-2D0D-485F-B440-7D0580D0C7AAQ38444551-D26C0C76-065C-4002-A05D-E5FD510E9471Q38626655-3571A048-069C-46C2-8A1C-6C1095552437Q39580232-1111EDEA-E84B-486D-8556-52EA162F5D6BQ47947938-2433AA50-1F7F-4BA6-9E24-D5B9A8F57DBAQ50674482-713D6A23-21C1-44F1-8CF0-D74F947E482D
P2860
Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Topiramate augmentation of clo ...... ind, placebo-controlled study.
@en
Topiramate augmentation of clo ...... ind, placebo-controlled study.
@nl
type
label
Topiramate augmentation of clo ...... ind, placebo-controlled study.
@en
Topiramate augmentation of clo ...... ind, placebo-controlled study.
@nl
prefLabel
Topiramate augmentation of clo ...... ind, placebo-controlled study.
@en
Topiramate augmentation of clo ...... ind, placebo-controlled study.
@nl
P2093
P2860
P50
P356
P1476
Topiramate augmentation of clo ...... lind, placebo-controlled study
@en
P2093
M Cacciola
P M Bellinghieri
S Settineri
P2860
P304
P356
10.1177/0269881110372548
P407
P577
2010-07-08T00:00:00Z